October 1 marked the start of the “America First Global Health Strategy,” and the rollout has already hit its first rough patches. The plan requires countries to sign a Memorandum of Understanding committing their own funds alongside U.S. investment. That means nations have to pledge to spend their own money to be eligible for U.S. funds.
The U.S. rationale is straightforward: protect the homeland from infectious disease outbreaks, and strengthen bilateral relationships through multi-year agreements. The strategy is being rolled out this fall, though implementation was originally scheduled to begin in April 2026 and has since been extended.
So far, the U.S. has signed MOUs with 35 countries committing around $14 billion in health investments over five years. Rwanda received $157 million from the U.S. and pledged $70 million in return. That deal also includes sharing patient data with the U.S. and accepting FDA approval of medicines without further Rwandan approval.
Three countries have refused to sign MOUs: Ghana, Namibia and Zimbabwe. Negotiations with Zambia stalled over provisions for U.S. access to critical minerals.
Mahama Rejects the Proposal
On September 25, Ghana’s president John Dramani Mahama rejected the American proposal during a U.N. General Assembly event. He called the funding offer “humiliating” and “a pittance, 100 and something million.”
The U.S. ambassador to Zimbabwe, Pamela Tremont, announced on the same day that all global health funding to Zimbabwe was stopped. Tremont said the U.S. would shift focus to economic investments and trade instead.
The Countries That Signed On
The U.S. has signed MOUs with Nigeria, Rwanda, the Philippines, Tajikistan, Bolivia and El Salvador. Those deals commit the countries to their own spending alongside U.S. investments.
Rwanda’s deal is the largest publicly detailed example. The country accepted the terms, including the data-sharing and FDA approval provisions. Whether other recipients have agreed to similar conditions is not yet clear.
The Countries That Refused
Ghana’s refusal was the most public. Mahama’s remarks at the U.N. made the rejection part of the international conversation. Namibia and Zimbabwe have also declined to sign.
The standoff with Zambia remains unresolved. The mineral-access provisions appear to be the sticking point, though details on what specifically was negotiated have not been released.
How the Strategy Works
The MOU requires countries to commit their own funds. The U.S. then provides its share of the investment over the course of the agreement.
The stated goal is to make countries more self-reliant. The logic is that shared investment creates a mutual stake in the partnership. If a country invests its own money, it has a stronger incentive to make the program work.
Whether that works in practice depends on how the MOUs are enforced. The administration says the requirement that countries chip in will make them more self-reliant and eventually less dependent on U.S. assistance.
The Fallout From the Rollout
The strategy has already produced visible friction. Ghana’s president rejected the offer publicly, and the U.S. responded by cutting off health funding to Zimbabwe.
The early signs are mixed. Rwanda accepted the terms. Ghana, Namibia and Zimbabwe did not. Zambia’s negotiations are stalled.
Where the paper stands
The paper backs no one here and takes no side, since both sides — the U.S. pushing its own health strategy and foreign governments asked to pledge their own funds — are caught up in arrangements the paper would rather see citizens manage for themselves rather than let one nation write the terms for all. The arrangement asks countries to sign on to spending commitments and data-sharing terms dictated by the U.S., while the U.S. reserves the right to cut off funding when a country refuses. That is not a model the paper endorses.
The standoff with Ghana, Namibia, Zimbabwe and Zambia shows the problem clearly. Each of these countries has refused or stalled over provisions for U.S. access to critical minerals, data sharing or FDA approval of medicines without further approval. The paper believes each country should be free to decide its own health investments and partnerships without being forced to accept another nation’s conditions.
The rollout has only just begun. October 1 was the start, and the coming months will show whether the strategy delivers on its promises or becomes a source of friction for the U.S. and its partners. The paper will continue to follow the rollout, paying closest attention to how the U.S. enforces its requirements and whether countries that signed on find the arrangement worthwhile.
Key Facts Box
- Rollout date: October 1
- Strategy name: America First Global Health Strategy
- MOUs signed: 35 countries
- Health investments committed: Around $14 billion over five years
- Rwanda deal: $157 million from U.S., $70 million pledged by Rwanda
- Refusals: Ghana, Namibia, Zimbabwe
- Stalled negotiations: Zambia
- U.S. response to Zimbabwe: All global health funding stopped
- Implementation start: Originally April 2026, now extended
The Verdict on the Plan
The rollout has exposed the tension at the heart of the strategy. The U.S. is asking for something it has rarely asked before: a commitment of a partner’s own money, paired with specific conditions on how that money is spent.
Ghana’s president put it bluntly. He called the offer “humiliating” and “a pittance.” That language suggests he saw the deal as an insult rather than a fair exchange.
The U.S. has not backed down. The cutoff of funding to Zimbabwe follows the administration’s stated position that countries refusing the agreement will lose health funding.
The strategy’s defenders argue that shared investment makes countries more self-reliant. That is a fair argument in theory. In practice, the pace of the rollout and the demands on sovereignty are raising questions.
The rollout is proceeding regardless of who signs on. The administration has made its position clear: the strategy continues even if some countries refuse to participate.
The question is whether the countries that signed on will find the arrangement worthwhile. If the U.S. funds arrive and the conditions hold, the strategy may prove effective. If the conditions are too burdensome, countries may rethink their participation.
The rollout has only just begun. October 1 was the start, and the coming months will show whether the strategy delivers on its promises or becomes a source of friction for the U.S. and its partners.
Source material: “October 1 ushered in a new era in U.S. foreign aid. What's the plan? Will it work?,” NPR.
Get the Notebook.
The day's best stories and every fresh verdict, in plain English, in your inbox by seven. One email a day, no more.